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Adipose tissue-derived ECM hydrogels and their use as 3D culture scaffold
Vasilena E. Getovaa, Joris A. van Dongena,b, Linda A. Brouwera and Martin C. Harmsena
aDepartment of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;
bDepartment of Plastic Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
ABSTRACT
Adipose tissue has the therapeutic capacity in the form of a fat graft, for example, for treatment of
irradiation-induced scars and difficult to heal dermal wounds. For large-scale clinical application, an off-
the-shelf product is warranted. In recent years, ECM-derived hydrogels are postulated to harbour thera-
peutic capacity and might even replicate the beneficial effects of adipose tissue. In normal homeosta-
sis, the natural ECM acts as a deposit of growth factors, that releases them over time. In the healing of
lesions, this might promote cell accumulation and proliferation which in turn stimulates angiogenesis
and repair. The decellularization of tissue and the generation of hydrogels may leave cytotoxic traces.
Therefore, our research assessed the cytotoxic effect of human adipose tissue-derived ECM hydrogels
on connective tissue cells i.e. fibroblasts. The results showed no cytotoxicity, meaning the hydrogels
caused no cell death. Cell migration and survival were observed when cultured in ECM hydrogels and
followed for 7 days. Cell survival in the hydrogel was confirmed with CFDA staining and also cells
showed the ability to penetrate and migrate throughout the gel. We conclude that ECM hydrogels are
promising to use as innovative therapy for wound healing.
ARTICLE HISTORY
Received 28 September 2018
Revised 9 April 2019







Adipose tissue has a beneficial role in wound healing [1,2].
Yet the underlying pathways are not completely understood.
This renders adipose tissue a novel, intriguing and exciting
territory in science, especially in the field of wound healing.
Lipografting is used in reconstructive- and plastic surgery
to restore loss of volume after breast surgery or to treat burn
wounds and augment wound healing [3,4]. Short term results
of lipografting are good, however, on the long-term; graft
survival is variable, ranging from 20–90% loss of volume after
injection [1]. In this way, the clinical efficacy of lipografting is
only temporary. To improve tissue grafting, scientists imple-
mented a technique where they combined adipose tissue-
derived stromal cells (ASC) with fat tissue [5].
The adipose tissue comprises parenchyma (adipocytes)
and stroma. Stroma comprises vasculature (endothelial and
smooth muscle cells as well as pericytes, adipose tissue-
derived stromal/stem cells (ASCs) and fibroblasts embedded
and held together by the extracellular matrix (ECM). The
stroma is also known as the stromal vascular fraction (SVF).
In general, most studies focus on ASCs as optimal candidates
for the repair of tissue damage or to facilitate angiogenesis,
for example in orthopaedics and cardiology [6–9]. The secre-
tome of ASCs stimulates angiogenesis which augments local
tissue perfusion. This paracrine action of ASCs comprises
secretion of pro-regenerative factors such as VEGF, FGF, and
HGF. In addition, ASCs contribute to repair by differentiation
into parenchymal or stromal cells, such as smooth muscle
cells, pericytes, fibroblasts, adipocytes or osteoblasts, depend-
ing on the damaged tissue [8]. We have shown that ASC-
derived pericytes both promote and stabilize vascularization
in vitro and in vivo in a NOTCH2-dependent fashion [10,11].
In these studies, we also cultured ASCs in 3D matrices of
commercial extracellular matrix i.e. MatrigelVR .
In the last 5 years, there is a new, promising player arising
in this field: the stromal vascular fraction [12–14]. Mechanical
isolation of SVF is faster and easier than the isolation and cul-
ture of ASCs [15]. SVF is shown to improve wound healing
rates faster compared to the injection of ASCs alone because
it contains multiple cell types including vasculature, fibro-
blasts and ECM, which are important in the wound healing
process. Moreover, ECM serves as a slow growth factor reser-
voir to which cells are able to attach to and can be sup-
ported by in growth and proliferation.
In the past years, ECM has been studied increasingly and
different regenerative therapies, with the use of ECM, are
developing in various medical fields [16]. ECM comprises the
non-cellular component of the tissue, occupies the space
between cells and functions as a scaffold to give structural
support to cells. ECM is composed of extracellular macromo-
lecules secreted by professional connective tissue cells such
as fibroblasts. The two main classes of macromolecules in
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ECM are (1) strongly negatively charged polysaccharides such
as glycosaminoglycans (GAGs) and proteoglycans (PGs) that
embed the (2) proteinaceous fraction of ECM such as colla-
gens. Collagen is the most abundant protein; and comprises
about 30% of the tissue mass (percentage various within dif-
ferent tissues types) and there are 28 different types of colla-
gens. PGs can either stimulate or inhibit angiogenesis in a
context-dependent manner. By virtue of their charge, PGs
and GAGs are very hydrophilic molecules that regulate tissue
volume by water retention which makes ECM, in fact, a nat-
ural hydrogel [17]. Moreover, ECM serves as a slow release
reservoir of growth factors that regulate the behaviour of
proximal cells. This ranges from suppression of apoptosis by
joint action ECM molecules and growth factors to prolifer-
ation, differentiation and migration. Growth factor binding
the GAGs in the ECM depends on the presence of the so-
called aminoterminal heparin-binding domain but also plain
electrostatic or Van der Waals interactions may keep soluble
factors bound to ECM.
A manner to implement the extracellular matrix as a treat-
ment or bioengineering tool is to produce ECM hydrogels.
Various human or porcine tissues qualify to produce organ-
specific ECM hydrogels including heart [18,19], lung [20], pan-
creas [21], skin [22], and adipose tissue [23]. We surmise that
these ECM hydrogels may act to retains growth factors with
the benefit that these are released with distinct kinetics over
time. The released growth factors are able to induce angio-
genesis by stimulation of endothelial cells to form new blood
vessels which, in turn, stimulates tissue regeneration resulting
in wound healing [24]. Wound healing is especially impaired
in diabetic patients because of decreased peripheral blood
flow leading to diabetic ulcers formation. Diabetes affects
ASCs and SVF, therefore, the clinical use of an ECM-derived
hydrogel from healthy donors is more suitable for patients
suffering from diabetes mellitus.
ECM hydrogels may also be applicable for 3D culturing,
3D bioprinting and in vivo tissue regeneration [25]. These
can be in a donor-independent fashion and over a species
barrier while SVF which can be used only as an allogeneic
transplant otherwise immunological rejection would occur.
More preliminary studies are needed before ECM hydrogel
can enter clinical trials. The decellularization of adipose tissue
precedes the generation of ECM hydrogels, the latter is done
by mild digestion under low pH with pepsin. In particular,
decellularization involves multiple steps with harsh chemicals
such as detergents that are incompatible with the survival of
cells. Therefore, the aim of this research was to assess the
influence of human adipose tissue-derived ECM hydrogels on
viability, proliferation and migration of therapeutic cells i.e.
ASCs and fibroblasts.
Materials and methods
Fractionation of adipose tissue procedure
The fractionation of adipose tissue (FAT) procedure was per-
formed as previously described [15]. Briefly, adipose tissue
was harvested during normal liposuction procedures and
transferred cooled from the operation room. Informed
consent was obtained according to the local ethical commit-
tee of the University Medical Center of Groningen. For the
FAT procedure, lipoaspirates were warmed to room tempera-
ture (RT) and divided into 50ml tubes. Then, lipoaspirate was
centrifuged at 956  g for 3min. at RT to separate adipose
tissue into three layers: oil, adipose tissue and infiltration
fluid. The oily fractions, as well as the infiltration fluid, were
discarded. Next, the centrifuged adipose tissue was placed in
a 10ml syringe and connected to the fractionator (a luer to
luer connector with three holes of 1.4mm inside). An empty
10ml syringe was connected on the other side of the fractio-
nator. Adipose tissue was pushed 30 times forwards and
back and the adipocytes were mechanically disrupted. Finally,
adipose tissue was centrifuged again at 956  g at RT for
3min. The second round of centrifugation yielded four frac-
tions: oily fraction, SVF and infiltration fluid containing a
small pellet. SVF was collected and washed with phosphate-
buffered saline (PBS) and stored at 20 C until further use
(Figure 1).
Decellularization of stromal vascular fraction
SVF was frozen with 50% ethanol/water in a 80 C fridge
for 2 h and thawed for 30–60min. for four cycles [26]. After
thawing, the 50% ethanol/water mixture was replaced every
time. Next, the SVF was incubated with 0.05% trypsin/
0.05mM ethylenediaminetetraacetic acid (EDTA) (1:1 v/v)
under constant stirring (Bambino machine) at 37 C for
90min. Then, samples were washed with phosphate buffered
saline (PBS) and sonicated (70W) with 0.5% sodium dodecyl
sulphate (SDS) at 46 C for 20min. Samples were centrifuged
and washed with PBS to completely remove SDS. Finally,
samples were lyophilized and subsequently immersed in
xylene and placed on a rolling bench for 17min. Afterwards,
samples were washed with PBS and subsequently washed
with 100% ethanol until the solution became clear. Samples
were incubated with DNAse solution (1:1 v/v) (LS002007,
Worthington, final concentration of 30 lg/ml DNAse in
1.3mM MgSO4 and 2mM CaCl2) overnight at 37 C. Next
day, samples were washed with PBS and again lyophilized.
Finally, samples were ground to a fine powder with an
UltraTurrax device (PM Tamson Instruments) and stored at
80 C until further use (Figure 1).
Gelation of decellularized adipose derived
extracellular matrix
ECM (20mg) was mixed with porcine pepsin powder (2mg,
3,200 I.U. Sigma-Aldrich) in 1ml 0.01M hydrochloric acid
(HCl). ECM was digested under constant stirring on a mag-
netic stirring device at 500 rpm at RT for 6 h. Afterwards, pH
was raised to 7.4 to neutralize the pepsin with 100 ll of 0.1M
sodium hydroxide (NaOH) to reach a final concentration of
0.01M NaOH. The pre-gel solution was buffered with 110 ll
of 10X PBS to reach a final concentration of 1X PBS. Then,
the pre-gel solution was mixed well and incubated for one
hour at 37 C to allow for gelation (Figure 1).
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Immortalization and lentiviral tagging of ASCs
Cultured human ASCs (pool of five donors, 1 million at pas-
sage 4) were transfected with 1 mg pMC1neo-polyA
(Stratagene) which is a plasmid encoding the large T antigen
of SV40 with neomycin as selectable marker [27,28]. At 48 h
post-transfection, transfected cells were selected by adding
250mg/ml geneticin (G418) to the medium. After 3 weeks,
colonies that remained were picked, subcultured and propa-
gated in medium with 250 mg/ml G418 for a second round of
selection. Stable cell lines were propagated and stored in
liquid nitrogen. For the current study, clone iADSC13 was
used and characterized. Tagging with CMV promoter-driven
reporter genes respectively EGFP (green fluorescence) or
dTomato (red fluorescence) was with third generation VSV-
pseudotyped replication-deficient lentiviruses. Up to three
rounds of transduction were done to increase the fraction of
reporter-expressing ASCs. These were named iADSC13EGFP
and iADSC13dTomato respectively. Additionally, transfected
cells were FACS-sorted, propagated and cryopreserved in
liquid nitrogen. Between 80 and 95% of the sorted ASCs
showed reporter expression that was detectable with a fluor-
escence inversion microscope, which sufficed for the
experiments.
Characterization and differentiation potential of
immortalized ASC
Flow cytometry
Immortalized ASC, lentivirally tagged with either EGFP or
dTomato, were analyzed using flow cytometry (FACS) for
CD surface marker expression. Cells were stained with the
following anti-human monoclonal antibodies: CD31- phycoer-
ythrine/cyanine7 (Pe/Cy7; eBioscience, Vienna, Austria),
CD45-fluorescein isothiocyanate (FITC; IQ Products) and
CD90-allophycocyanin (APC; BD Bioscience, San Jose, CA).
CD29-APC (eBiosience), CD44-FITC (BD Bioscience) and
CD105-Pe/Cy7 (eBiosience). For controls, we used the follow-
ing monoclonal antibodies: Mouse IgG1 kappa-Pe/Cy7, Mouse
IgG1 kappa-APC (both eBioscience), IgG2b FITC (BD
Bioscience) and IgG1 FITC (IQ products). Cells were mixed
with the antibodies and incubated for 30min.
Adipogenic, osteogenic and smooth muscle cell differenti-
ation assay
Basal medium DMEM (BioWhittaker Walkersville, MD) contain-
ing 10% foetal bovine serum (FBS), 1% penicillin/strepto-
mycin and 1% glutamine was used. Immortalized ASC,
Figure 1. Overview of preparation method of an ECM hydrogel from human adipose tissue. SVF: stromal vascular fraction; ECM: extracellular matrix.
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tagged with EGFP or dTomato, were cultured to confluency
and medium was changed to promote differentiation. For
adipogenic differentiation this was basal DMEM plus 0.1 mM
dexamethasone, 1 nM insulin, 0.5mM isobutymethylxanthine.
For osteogenic differentiation this was basal DMEM plus
0.1mM dexamethasone, 10mM b-glycerophosphate and
0.05mM ascorbic acid. Finally, smooth muscle cell differenti-
ation was in basal DMEM plus with 10 ng/ml TGF-b1. After
14 days culture in the differentiation medium, cells were fixed
with 2% PFA and stained for Oil Red O (Sigma-Aldrich, St.
Louis, MO) for adipogenic differentiation, Alizarin Red (Sigma
Aldrich) for osteogenic differentiation and Phalloidin-FITC
(Invitrogen, Thermo Fisher Scientific, Renfrewshire, Scotland)
in DAPI for 30min for smooth muscle cell differentiation.
Colony formation assay
Tagged ASCs were seeded at, respectively, hundred and
thousand cells per well of a six-well culture plate in duplicate
and were cultured for 14 days. Cells were washed with PBS
and fixed with 2%PFA in PBS for 15min. Cells were washed
well with PBS and stained with Crystal Violet (Sigma-Aldrich).
Plates were scanned and the ability to form colonies was
assessed by determining the area of the colonies.
Histological characterization of acellular matrix by
haematoxylin and eosin
Cryo-sections of 12 mm were made from snap-frozen adipose
tissue, SVF and ECM derived from the same donor (n¼ 17).
Samples were stained with haematoxylin solution for 5min.
After staining, samples were washed with tap water for
5min. Afterwards, samples were stained with eosin solution
for 10min. and subsequently washed with tap water for
5min. Finally, samples were mounted with Aquatex and
visualized under light microscope (Leica Microsystems,
DM IL).
MTT conversion assay for cell viability
Hydrogels (n¼ 3) in triplicate were prepared in a 24 well
plate with a volume of 0.5ml. One millilitre of culture
medium (basal DMEM) was placed on top of each hydrogel
and collected every 24 h for 4 days. Conditioned medium
from each hydrogel for each time point was used in tripli-
cate. A serial twofold dilution series of the hydrogel-derived
medium was used.
Human dermal fibroblasts (PK84) were cultured in 96 well
plates in culture medium (as previously described) until con-
fluency. Culture medium was replaced with the dilution series
of hydrogel-derived medium for 48 h. As a positive control
for cytotoxicity, a twofold serial dilution series of puromycin
(Gibco, 10mg/ml) in the medium was used, starting at 10 ll
per well. Normal culture medium served as a nega-
tive control
After 48 h, 5mg/ml MTT (3–(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) in PBS was added to each well.
Plates were incubated at 37 C for 3 h. Afterwards, the
medium was removed and the purple formazan crystal dis-
solved in 200 ml of dimethyl sulfoxide (DMSO) by careful mix-
ing. Optical density was measured at 650 nm and 585 nm.
The difference in optical density between 650 nm and
585 nm was plotted against the log dilution to generate cyto-
toxicity graphs. Results were analyzed with GraphPad Prism 7
(CA, USA) using a nonlinear regression for a dose-response
inhibition. The half maximal inhibitory concentration (IC50)
was used as an indicator of cytotoxicity. The IC50 value indi-
cates how much of the substance is needed to induce 50%
of cell death.
Live/dead staining of ASCs on hydrogels
Hydrogels (n¼ 3) in triplicate were prepared in a 24 well
plate with a volume of 0.5ml Hydrogels were incubated with
1ml of basal medium (as previously described in 2.5) for
8 days and replaced every day. A suspension of 300 ml of
culture medium containing 200,000 immortalized ASCs was
added on top of each hydrogel. Immortalization was per-
formed with the large T antigen of SV40 and lentivirally
tagged (Harmsen lab, described in 2.4) with enhanced
GFP (green, iASC13EGFP) or with dTomato (red,
iADSC13dTomato). Cells were evaluated for 7 days. Culture
medium was changed every day and micrographs were taken
every day. After 7 days, a live/dead staining was performed
with CFDA-SE (1:2000), PI (1:500) and DAPI (1:5000) for
iASC13GFP. For iADSC13dTomato only CFDA-SE and DAPI
were used, PI staining was not used as it has the same wave-
length as already pre-stained cells, therefore they are both
the same colour and it cannot be differentiated. As a control,
1300 ml of culture medium containing 200,000 iASC13EGFP in
a 24 well plate was used. Samples were visualized with an
immunofluorescence microscope (EVOSVR FL Cell Imaging
System). After evaluation, samples were fixed with 2% paraf-
ormaldehyde in PBS for 30min. Finally, samples were
embedded in paraffin for immunohistology staining.
Immunohistology staining of ASCs inside hydrogels
From the above-mentioned paraffin embedded hydrogels
(2.6), 4 mm sections on adhesive slides were made with Leica
Reichert-Jung 2055 microtome. Samples were deparaffinized
and incubated overnight with 0.1M Tris/HCl solution (pH 9.0)
at 80 C. Next day, samples were stained with haematoxylin
for 4min. and mounted with Aquatex. Results were evaluated
with a light microscope (Leica Microsystems, DM IL).
Results
Characterization of immortalized ASC
Immortalized ASC retain ASC characteristics
A mean of 98.9, 99.0, 95.9 and 23% of the immortalized ASCs
showed expression of CD29, CD44, CD90 and CD105.
Endothelial marker CD31 and common leukocyte marker
CD45 was not detected. These results show that the
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lentivirally tagged immortalized ASC have a similar surface
marker expression as ASC (Figure 2) [15].
Immortalized ASC retain cell differentiation capacity to
adipocytes, osteoblasts and smooth muscle cells
Immortalized ASC successfully differentiated to adipocytes,
osteoblasts and smooth muscle cells. This is coherent with
the differentiation ability of normal, human isolated ASC
(Figure 3) [15].
Immortalized ASC retain colony formation capacity
The number of colonies in each well consisting of more than
50 cells varied between 3–7%. This is coherent with results
reported from colony experiments with normal, human ASC,
where the number of colonies should be between
0.1–5% [15].
Extracellular matrix derived hydrogels are non-cytotoxic
The serial sampling at 24 h intervals of possible cytotoxic
elutes from hydrogels showed no difference in MTT conver-
sion compared to medium controls. Therefore, no IC50 could
be calculated for all time points of each hydrogel indicating
that the hydrogels did not release any cytotoxic compounds
over time (Figure 4). Results showed that positive control
(puromycin) induced a strong cytotoxic response
(LogIC50 3.1–3.6mM).
Figure 2. Representative data of CD-surface marker expression in immortalized ASCs.
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No dead cells present in extracellular matrix
derived hydrogels
Live/dead staining showed no dead cells (PI-stained nuclei) in
hydrogels nor control (Figure 5) ASCs appeared to adhere to
the hydrogels and acquire the typical spindle-shape of mes-
enchymal cells; similar to the controls seeded on flat tissue
culture plastic (Figure 5(B,D,F)). It appeared that ASCs were
more stretched when cultured in hydrogels than on tissue
culture plastic (Figure 5). Cell density did not appear to differ
between ASC seeded on hydrogels as compared to tissue
culture plastic controls, although quantification was not pos-
sible. The visualization even of fluorescently labelled ASCs
(Figure 5(A,C,E)) on and in hydrogels is challenging due to
the limited depth of field with the microscope.
Histological confirmation of ASCs present inside
the hydrogels
Haematoxylin-stained thin section of paraffin-embedded
hydrogels confirmed the presence of ASCs inside the hydro-
gels (Figure 6A) and at the periphery below the gel surface
(Figure 6(B)).
Discussion
The results of this research show that human adipose tissue-
derived ECM hydrogel is non-cytotoxic and support adhesion,
survival as well as migration and proliferation of immortalized
ASCs. These are promising results that warrant further imple-
mentation e.g. as a delivery vehicle of stem cells, in animal
and later also clinical trials. Cells cultured in the 3D hydrogel
environment showed different morphology with respect to
extending and elongating structures compared to cell
morphology in plain cell culture plastic 2D environment cul-
ture. We also showed that immortalized ASC show the same
characteristics as normal ASC (CD markers, colony forming
ability and differentiation ability).
ECM derived hydrogels can have various implementa-
tions. ECM hydrogels are currently being used as a 3D cul-
turing model and as bioengineering printing bio-ink. As
shown by this study, culturing of cells differs in a 2D
environment as compared to a 3D environment, especially
in morphology. A study by Sung et al. showed that fibro-
blast in 3D culture released more signalling molecules
which resembles more precisely their behaviour in the
human organism [29]. Therefore, a 3D ECM hydrogel cul-
ture system is a better representative of how processes in
the human body function and, therefore, an ideal culture
system to study the effect of treatments on different cellu-
lar processes. The ECM hydrogels will likely impact bio-
engineering, as bio-ink for printing organoids together with
vascular and connective tissue cells.
Currently, ECM hydrogels from different origins have
been tested in a variety of medical fields [18–22]. A study
by Ghuman et al. induced a stroke in rats and subse-
quently injected an ECM hydrogel derived from adult por-
cine urinary bladder tissue into the necrotic stroke area
[30]. This resulted in increased tissue regeneration in the
brain after injection of an ECM hydrogel. The injected ECM
hydrogel caused more cell infiltration as compared to the
control group. Although different origins of the extracellu-
lar matrix are available, the use of human adipose tissue-
derived ECM provides several advantages as compared to
decellularized tissue from other origins. First, human adi-
pose tissue is more easily accessible without adverse side-
effects compared to other organs of the human body such
as skin. Second, human adipose tissue is widely available
since patients frequently donate liposuction adipose tissue.
Third, the obtained adipose tissue-derived ECM can be
used as both autologous as well as an allogeneic treat-
ment modality, while autologous transplantation is not pos-
sible for most of the other decellularized organs of the
Figure 3. Immortalized ASC retain cell differentiation capacity to adipocytes, osteoblast, smooth muscle cells. (A) Immortalized ASC differentiated to adipocytes. (B)
Differentiated to osteoblasts. (C) Differentiated to smooth muscle cells.
Figure 4. Optical density plotted against the serially diluted CMe from human
adipose tissue-derived hydrogels after four different time points (log scale).
PK84 fibroblasts were treated with hydrogel CMe or controls for 48 h.
Puromycin was used as positive control. Normal culture medium was used as
negative control. Results are presented as mean with standard error of the
mean of triplicates of three independent donors. CMe: conditioned medium.
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human body (e.g. heart, lung). Allogeneic transplantation is
possible due to the lack of a cellular component causing
an immune response after transplantation.
This study served to set up a platform technology and
focused on the potential adverse influence of ECM hydro-
gels on two stromal cell types ASC and fibroblasts.
Current research comprises of co-culture systems in ECM
hydrogels of different organs and investigating processes
relevant to tissue regeneration such as vascularisation.
Thus, co-cultures of two or more different cell types are
under investigation. Besides, physical features of hydrogels
such as matrix stiffness and viscoelasticity are under inves-
tigation now.
In conclusion, the results of this research showed that
human adipose tissue-derived ECM hydrogels are not cyto-
toxic and support adhesion and (in)growth of human immor-
talized ASCs. These results are promising and warrant further
research about the implementation of adipose tissue-derived
hydrogels as e.g. a delivery vehicle of cell types or bioengin-
eering printing bio-ink.
Figure 5. (A,C,E) Representative fluoromicrographs of iASC13EGFP cultured on top of human adipose tissue-derived ECM hydrogels after respectively 1, 6 and
6 days. (B,D,F) Representative fluoromicrographs of iASC13EGFP cultured on tissue culture plastic (control) for respectively 1, 6 and 6 days. Scale bar: A–D: 400mm,
E–F: 200 mm. iASC13EGFP: immortalized EGFP-tagged adipose derived stromal cells; ECM: extracellular matrix.
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